dr. yoshino on u3-1565 and tas-102 in colorectal cancer
Published 11 years ago • 386 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
0:55
dr. yoshino discusses the safety profile of tas-102
-
4:58
tas-102 in refractory metastatic colorectal cancer
-
6:43
tas-102 in metastatic colorectal cancer
-
4:19
the role of tas-102 in metastatic colorectal cancer
-
5:42
role of tas-102 (trifluridine/tipiracil) in advanced colorectal cancer
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
3:39
impact of tas-102 in metastatic colorectal cancer - video abstract id 113320
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
4:54
the first oral fluoropyrimidine for mcrc—tas-102
-
4:30
trifluridine/tipiracil in advanced colorectal cancer
-
2:49
management of side effects with tas-102
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
0:50
dr. wu on possible combinations with tas-102 in crc
-
9:06
debate: is there an optimal treatment for refractory colorectal cancer? - tas-102 or regorafenib
-
6:00
ftd/tpi bev and ftd/tpi provides benefits for metastatic colorectal cancer patients
-
13:46
debate 3: salvage therapy for mcrc? - tas-102